It's that time of the year when journal metrics are updated... Thanks, as ever, to our authors, peer reviewers, advisory board, & colleagues, who enable us to continue publishing work that changes the lives of those living with digestive diseases. #GITwitter #LiverTwitter

Giving Bluesky a go... https://t.co/MGLGlKrXpn #GITwitter #LiverTwitter

New research - D’Haens et al - Vedolizumab to prevent postoperative recurrence of Crohn's disease (REPREVIO): a multicentre, double-blind, randomised, placebo-controlled trial https://t.co/LHekfxk9p0 #GITwitter #IBD

Individuals with type 2 diabetes are at higher risk for clinically relevant liver disease. Could including liver health checks in annual diabetes reviews allow early interventions to prevent end-stage liver disease? https://t.co/KTe2yqKB1s #LiverTwitter #WorldDiabetesDay

In case you missed the webinar we hosted with @LancetGastroHep at @LGCW2024 on how to prevent #livercancer via #hepatitis elimination, you can watch it here: https://t.co/8JzX8MaeLj #LiverTwitter

The first-ever #HepTestWeek is here! Viral hepatitis is the leading cause of liver cancer. Knowing your hepatitis status is the first step to accessing life-saving treatment and care. This week, take charge of your health—get tested for hepatitis! 💪 Protect yourself, your

In the latest episode of our podcast, we talked to #PeterDeCruz about what the results of the PREDICT-UC trial mean for the management of people with steroid-refractory acute severe ulcerative colitis (ASUC) 🔊 https://t.co/XxpGywY1lI 📃 https://t.co/GYA3Nef5Hl

Attending #TLM24? Rob Brierley, Editor-in-Chief, invites you to reach out with enquiries. Explore our scope, reach & impact, commitment to publishing excellence, & more: https://t.co/qmHGdpodEl #LiverTwitter

@uicc Rachel Halford (who is also president of @Hep_Alliance) sums up. We have the tools to tackle viral hepatitis + prevent liver cancer; "no-one should have to die from liver cancer" #LiverTwitter #OncTwitter #NoHep #LGCW2024

Sonali Johnson (@UICC) discusses how to bring together hepatitis & oncology communities to accelerate elimination of viral hepatitis & prevention of liver cancer; we must "demand a seat at the table" in development of national cancer control policies #LGCW2024 #LiverTwitter

Maia Tsereteli (National Centre for Disease Control & Public Health, Georgia) & Kiyono Souichirou (MoH, Japan) share national experiences—and great successes—in tackling viral hepatitis & liver cancer #LGCW2024 #LiverTwitter #OncTwitter

@funmilesi @LewisRobertsMD @HepatitisCTrust @Hep_Alliance .@simbamabaya from @gavi outlines the importance of #HBV vaccination, and particularly scaling up availability of birth dose HBV vaccines #LiverTwitter #OncTwitter #NoHep #LGCW2024

@funmilesi @LewisRobertsMD @HepatitisCTrust Rachel and authors from the @Hep_Alliance introduce the first World Hepatitis Testing Week, taking place next week Nov 18th, in this new Comment: https://t.co/5LuiVzyvQS #LiverTwitter #OncTwitter #NoHep #LGCW2024

@funmilesi @LewisRobertsMD Rachel Halford, CEO @HepatitisCTrust, discusses the vital role of timely testing for #HCV for liver cancer prevention, told through Neil's story - watch the video here: https://t.co/sCgq2DJdm7 #LiverTwitter #OncTwitter #NoHep #LGCW2024

@funmilesi @LewisRobertsMD now discusses the global liver cancer situation - liver cancer is lethal, widespread, and affects those of working age disproportionately, and viral hepatitis is a critical, treatable, risk factor #LiverTwitter #OncTwitter #NoHep

WHO's @funmilesi is the first speaker, introducing the urgent need to address viral hepatitis, the importance of the new #hepatitisB guidelines, and the four key actions that can drive global hepatitis elimination by 2030 #LiverTwitter #OncTwitter #NoHep

Happening NOW - find out how liver cancer can be prevented via the elimination of viral hepatitis! A webinar for @LGCW2024 in conjunction with @hepatitisfund Register and watch: https://t.co/ZguibDLzJJ… #LiverTwitter #OncTwitter #NoHep

The December issue of @LancetGastroHep is out now! A summary of content 👉 https://t.co/30BwojMlnI #GITwitter #LiverTwitter #MedTwitter

Looking forward to this webinar on preventing liver cancer through viral hepatitis elimination, which I'll be moderating alongside Jade Chakowa of @hepatitisfund next Weds, Nov 13th! More info👉 https://t.co/spYeKZ0yj5 Register 👉 https://t.co/pCvfSsHdp8 #LiverTwitter #NoHep

Join a virtual expert panel, hosted by @hepatitisfund & @LancetGastroHep, to discuss opportunities to prevent liver cancer via accelerating efforts to eliminate viral hepatitis Date: Nov 13, 2024 Time: 1200-1300 GMT Register here: https://t.co/ZguibDLzJJ #LGCW2024 #NoHep